Adicet Bio Leadership Team
The Opportunity to Make an Extraordinary Difference
Adicet Bio, Inc. is a well-funded, preclinical stage biotechnology company that is engaged in the development of cutting-edge immunotherapies that have the potential to profoundly transform the treatment of cancer and other diseases. -Off the-shelf allogeneic T cell therapy with enhanced value to patient and the healthcare system -Healthy donor cell banks can treat many patients -Reduced cost of manufacturing -No graft versus host disease (GvHD) anticipated
Named as One of FierceBiotech’s “Fierce 15” Biotech Companies